Renaissance Technologies’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Renaissance Technologies's BLTE Position: Q3 2026 in Review
Renaissance Technologies reduced its Belite Bio (BLTE) stake by 41% in Q3 2026, selling an estimated $3.73M and leaving 32,800 shares worth $5.57M. The position accounts for 0.01% of the portfolio, ranked #1399.
Renaissance Technologies first reported a position in BLTE in Q4 2023 and has held it in 6 quarters since. The position peaked at $8.59M in Q2 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Renaissance Technologies held 32,800 shares of Belite Bio worth $5.57M as of Q3 2026.
- Renaissance Technologies sold 22,963 Belite Bio shares in Q3 2026, an estimated $3.73M.
- Belite Bio made up 0.01% of Renaissance Technologies's portfolio in Q3 2026, its #1399 holding.
- Renaissance Technologies first reported a position in Belite Bio in Q4 2023 and has held it in 6 quarters since.
- Renaissance Technologies's Belite Bio position peaked at $8.59M in Q2 2026.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.